SCHEMBL29925432

SCHEMBL29925432

CC1(C)OB(c2ccc3c(c2)oc2ccccc23)OC1(C)C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LPL P06858 7/20 0.49
LIPG Q9Y5X9 7/20 0.49
CSF1R P07333 1/20 0.47
AHR P35869 2/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
PGR P06401 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAOA P21397 3/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484105 1.00 LPL (0.49) LPLLIPGCSF1RAHRMEN1
SCHEMBL31158057 1.00 LPL (0.49) LPLLIPGCSF1RAHRMEN1
SCHEMBL22737977 0.94 LIPG (0.51) LPLLIPGCSF1RAHRMEN1
SCHEMBL21019297 0.92 LPL (0.45) LPLLIPGCSF1RAHRMEN1
SCHEMBL19831190 0.92 CSF1R (0.52) LPLLIPGCSF1RMAPTKDM4E
SCHEMBL24264177 0.92 LIPG (0.49) LPLLIPGCSF1RAHRMEN1
SCHEMBL20321608 0.91 LPL (0.46) LPLLIPGCSF1RAHRMEN1
SCHEMBL2037575 0.90 LPL (0.49) LPLLIPGCSF1RAHRMEN1
SCHEMBL24097611 0.90 LIPG (0.48) LPLLIPGCSF1RAHRMEN1
SCHEMBL24264228 0.90 LIPG (0.48) LPLLIPGCSF1RAHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12514107-B2 Organic electroluminescent apparatus MERCK PATENT GMBH (DE) 2025-12-30 US disclosed
US-20250115630-A1 METAL COMPLEXES UDC IRELAND LTD (IE) 2025-04-10 US disclosed
US-12180233-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-12-31 US disclosed
US-20230157151-A1 ORGANIC ELECTROLUMINESCENT APPARATUS MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
EP-3752512-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-03-01 EP disclosed
US-20220289778-A1 METAL COMPLEXES UDC IRELAND LIMITED (IE) 2022-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12180233-B2 Metal complexes IMMT, MCU, SOD1 LPL 3959/4885LIPG 3702/4885CSF1R 3953/4885
US-20250115630-A1 METAL COMPLEXES IMMT, MCU, SOD1 LPL 3959/4885LIPG 3702/4885CSF1R 3953/4885
US-12514107-B2 Organic electroluminescent apparatus SCO2, RIF1, RER1 LPL 3601/4885LIPG 4217/4885CSF1R 2457/4885
US-20220289778-A1 METAL COMPLEXES IMMT, MCU, SOD1 LPL 3959/4885LIPG 3702/4885CSF1R 3953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.